Lee Haikal, MD
Vascular & Interventional Radiology · Huntington, WVNPI 1952388548
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Penumbra, Inc. at 31.9% of the total. Reporting peaked in 2024 at $3,340 and has fallen 66.1% since, to $1,131 in 2025.
Across 70 payments — averaging $89.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Heartflow, Inc.$1K
- Stryker$1K
- United Imaging Healthcare North America LLC$383
- Terumo Medical Corporation$237
- Advanced Critical Devices, Inc.$163
- plus $697 from 11 others
What the payments were for
- Travel & lodging$3,42255%
- Food & beverage$2,82145%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 29 | $1,994 |
| Heartflow, Inc. | 10 | $1,452 |
| Stryker | 7 | $1,317 |
| United Imaging Healthcare North America LLC | 2 | $383 |
| Terumo Medical Corporation | 4 | $237 |
| Advanced Critical Devices, Inc. | 2 | $163 |
| Inari Medical, Inc. | 2 | $159 |
| Histosonics, Inc. | 1 | $142 |
| W. L. Gore & Associates, Inc. | 1 | $72 |
| Cook Medical LLC | 3 | $68 |
| Bard Peripheral Vascular, Inc. | 1 | $62 |
| Johnson & Johnson | 1 | $56 |
| Shockwave Medical, Inc | 2 | $56 |
| Medtronic | 2 | $29 |
| Galvanize Therapeutics, Inc | 1 | $22 |
| Boston Scientific | 1 | $19 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,487
- AUGMENT INJECTABLE$1,167
- FFRct$1,161
- uAngio Aviva$383
- Azur CX Detachable$177
How this compares
Too few vascular & interventional radiology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 13 | $145 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Huntington
- Michael KoronaHuntington$9K
- James MartinHuntington$2K
- Alexander ChristieHuntington$2K
- James ReynoldsHuntington$2K
- Paul BlomHuntington$2K
- Nathan HatfieldHuntington$869
- Robert GrammerMorgantown$262K
- Amy DeipolyiCharleston$83K
- Jeffery MeadowsMorgantown$6K
- Vivek PadhaMartinsburg$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.